Circulating Tumor DNA-based Minimal Residual Disease Detection in Colorectal Cancer Management : Episode 3
Circulating Tumor DNA Detection Techniques
Experts outline circulating tumor (ct) DNA analysis, detailing the two main techniques and their respective advantages and disadvantages.
- Dr Kopetz: Please describe circulating tumor (ct) DNA analysis, highlighting the two primary techniques and the pros and cons of each
- Tumor-informed techniques (e.g., Signatera and Safe-SeqS)
- Tumor-agnostic or tumor-naïve techniques (e.g., Guardant Reveal)
Recent Videos
Related Content
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024Article
The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
